Showing 23,141 - 23,160 results of 42,907 for search '(( 50 ((a decrease) OR (nn decrease)) ) OR ( e ((mean decrease) OR (point decrease)) ))', query time: 1.35s Refine Results
  1. 23141

    Data Sheet 1_Sex differences in the reactivity of gastric myoelectrical activity and heart rate variability as putative psychophysiological markers in human pain research.docx by Rossitza Draganova (9154951)

    Published 2024
    “…HRV analyses revealed increases in SDNN, RMSSD, and pNN50 during pain, indicating sympathovagal regulation changes. …”
  2. 23142

    Data_Sheet_1_Effect of Virtual Reality on Stress Reduction and Change of Physiological Parameters Including Heart Rate Variability in People With High Stress: An Open Randomized Cr... by Hyewon Kim (1788081)

    Published 2021
    “…However, there was a significant difference in electromyography, LF/HF ratio, LF total, and NN50 between VR relaxation and biofeedback.…”
  3. 23143

    Supplementary Material for: Rationale and Design of a Randomized Placebo-Controlled Clinical Trial Assessing the Renoprotective Effects of Potassium Supplementation in Chronic Kidn... by Gritter M. (5468213)

    Published 2018
    “…Secondary end points include other renal outcomes (> 30% decrease in eGFR, doubling of serum creatinine, end-stage renal disease, albuminuria), ambulatory blood pressure, CV events, all-cause mortality, and incidence of hyperkalemia. …”
  4. 23144
  5. 23145
  6. 23146
  7. 23147
  8. 23148
  9. 23149

    Role of BAT3 for iDCs and the effect of purified BAT3 on NK cell function. by Venkateswara Rao Simhadri (376438)

    Published 2013
    “…The y-axis represents the mean fluorescence intensity (MFI). (E) The lysis of Raji cells is inhibited by soluble BAT3 and anti-NKp30 compared to the control protein His BB4. …”
  10. 23150

    Effects of CER on vascular calcification and phenotypic change in P<sub>i</sub><i>‐</i>treated VSMCs. by Razia Rashid Rahil (22772495)

    Published 2025
    “…Bar graphs depicted significant decrease in mRNA expression of (C) α -SMA (D) SM22α and increased (E) RUNX2 (F) OPN and (G) BMP2 in CER treated P<sub>i</sub>-induced VSMCs. …”
  11. 23151

    NIH3T3 cells expressing Cx43dT-GFP show defects in wound closure and polarized cell movement. by Richard Francis (201117)

    Published 2011
    “…The rate of wound closure in the Cx43dT-GFP transfected cells (E, F) was reduced when compared with the GFP (A,B) or Cx43FL-GFP transfected cells (C,D). …”
  12. 23152
  13. 23153

    SA00025 induced anti-inflammatory activity in the 6-OHDA lesion model primed with dsRNA inflammatory stimulant (poly(I:C)). by Gaynor A. Smith (713611)

    Published 2015
    “…Optical density analysis indicated that Nurr1 agonist treatment caused a significant decrease in IBA-1 (D) and GFAP (E) staining in the SNpc, compared to vehicle conditions. …”
  14. 23154

    mEPSC amplitude and frequency change in Hu97/18 SPNs. by Karolina Kolodziejczyk (550934)

    Published 2014
    “…There was no difference between Hu18/18 and Hu97/18 SPNs. (E) The mean mEPSC frequency trended towards a decrease in Hu97/18 SPNs but did not reach statistical significance (p = 0.052). …”
  15. 23155

    Effects of pharmacological blockade of GJ channels on epileptiform potentials during status epilepticus (SE). by Erika R. Kinjo (642091)

    Published 2014
    “…Bars represent standard errors of mean. *<i>P</i><0.01 in T-Test.</p>…”
  16. 23156

    Metabolic endpoints measure response in SCC25 and SCC61 after treatment. by Amy T. Shah (530305)

    Published 2014
    “…Treatment with BGT226 or cisplatin treatment decrease proliferation. (e) The ratio of lactate production/glucose consumption reflects rates of glycolysis, which decreases after treatment with BGT226 and cisplatin in SCC25 cells and after treatment with cetuximab, BGT226, and cisplatin in SCC61 cells. …”
  17. 23157

    Morphologic and behavioral changes observed in <i>ddc</i> morphants. by De-Fen Shih (441898)

    Published 2013
    “…All results were expressed as mean±SD. *<i>p</i><0.05, **<i>p</i><0.01, ***<i>p</i><0.001 compared to control larvae.…”
  18. 23158

    Palmitate induces PGC−1α promoter methylation in primary microglia. by Xiaomin Su (784467)

    Published 2015
    “…<b>E.</b> Quantitation of mitochondria DNA (mtDNA) to nuclear DNA (nuDNA) ratio using real-time PCR. mtDNA:nuDNA ratio was decreased by 49.7% in 0.5 mM palmitate-treated microglial cultures compared to control (p = 0.046). …”
  19. 23159

    Palmitate induces PGC−1α promoter methylation in primary astrocytes. by Xiaomin Su (784467)

    Published 2015
    “…<b>E.</b> Quantitation of the mitochondria DNA (mtDNA) to nuclear DNA (nuDNA) ratio using real-time PCR. mtDNA:nuDNA ratio was decreased by 28.1% in 0.5 mM palmitate-treated astrocyte cultures compared to control (p = 0.0006). …”
  20. 23160

    Supplementary Material for: Selective Serotonin Reuptake Inhibitors and Serotonin Noradrenaline Reuptake Inhibitors withdrawal changes DSM presentation of mental disorders: Results... by Cosci F. (4134769)

    Published 2024
    “…Using a new nosographic classification of withdrawal syndromes due to SSRI/SNRI decrease or discontinuation (by Chouinard and colleagues), we explored whether DSM is adequate to identify DSM disorders when withdrawal occurs. …”